YP
Yogita Prashant Jagadale
About Yogita Prashant Jagadale
Data last updated:
Yogita Prashant Jagadale is a Director at Endovision Pharma Private Limited (since 2025) and Director at Endospy Pharmaceuticals Private Limited (since 2022). The companies operate in Healthcare and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹21.9 Lakh; the largest is Endovision Pharma Private Limited at ₹13.4 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Endovision Pharma Private Limited U51909PN2021PTC198478 | Director | 28 Aug 2025 | 2021 | ₹13.4 Lakh (FY 2022) | Active |
| Endospy Pharmaceuticals Private Limited U24230PN2022PTC213872 | Director | 15 Aug 2022 | 2022 | ₹8.5 Lakh (FY 2025) | Active |
Board colleagues of Yogita Prashant Jagadale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prashant Bhanudas Jagadale | 09061694 | Endovision Pharma Private Limited , Endospy Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogita Prashant Jagadale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogita Prashant Jagadale
Yogita Prashant Jagadale currently holds 2 directorships: Endovision Pharma Private Limited (Director, since 28 Aug 2025, revenue ₹13.4 Lakh (FY 2022)); Endospy Pharmaceuticals Private Limited (Director, since 15 Aug 2022, revenue ₹8.5 Lakh (FY 2025)).
Yogita Prashant Jagadale was first appointed on 15 Aug 2022 as Director at Endospy Pharmaceuticals Private Limited. The most recent appointment on record is 28 Aug 2025 at Endovision Pharma Private Limited.
The 2 current companies of Yogita Prashant Jagadale that report revenue have a combined latest revenue of ₹21.9 Lakh: Endovision Pharma Private Limited ₹13.4 Lakh (FY 2022); Endospy Pharmaceuticals Private Limited ₹8.5 Lakh (FY 2025).
The current boards of Yogita Prashant Jagadale's companies include Prashant Bhanudas Jagadale (Endovision Pharma Private Limited).